Tongue scraping may freshen breath in gum disease patients
NCT ID NCT06091228
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether adding tongue scraping to standard gum disease treatment can improve bad breath. About 39 adults with gum disease and bad breath will either get standard care or standard care plus twice-daily tongue scraping. Researchers will measure breath odor and sulfur compounds to see if the tongue scraper makes a difference.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- tongue scraper
- What this could lead to
- If it works, this could point toward a simple, low-cost addition to gum disease treatment that helps reduce bad breath.
- What could go wrong
- This is a small, early-stage study with only 39 participants, so results may not apply to everyone. Tongue scraping is generally safe but may cause gagging or irritation.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 39 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Sep 2024
- Expected to finish
-
Dec 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Voluntary written informed consent of the participant or their legally authorized representative has been obtained prior to any screening procedures * Males or females American Society of Anesthesiologist classification I of II, * 18 years of age or older, * In good general health as documented by self-assessment * Suffer from generalised periodontitis (according to 2018 classification) * Suffer from halitosis with suspected intra-oral cause: organoleptic score (OLS) of 2 or higher by an experienced oral malodour judge * At least one volatile sulphur compounds(VSCs) measurement above the following thresholds: 1. Portable sulphur detector (Halimeter) \> 107 ppb 2. Oral Chroma™: hydrogen sulfide (H₂S) \> 112ppb 3. Oral Chroma™: methyl mercaptan (CH3SH) \>28ppb Exclusion Criteria: * Participant has a history of chemotherapy or radiotherapy in head and neck area * Any disorder, which in the Investigator's opinion might jeopardise the participant's safety or compliance with the protocol * Any prior or concomitant treatment(s) that might jeopardise the participant's safety or that would compromise the integrity of the Trial * Female who is pregnant, breast-feeding or has the intention of becoming pregnant in the following 6 months * Participation in another interventional Trial with an investigational medicinal product (IMP) or device * Recent intake of antibiotics (3 months prior to the first consultation) * Antibiotics indicated as part of the periodontal treatment * Use of antibiotics during the course of the study * Suffer from halitosis with suspected extra-oral cause * Suffer from a systemic disease that could cause extra-oral halitosis (e.g. diabetes mellitus, liver or kidney failure, trimethylaminuria) * Participant has a history of rheumatic fever, neurological deficiencies, or use of medication which may affect periodontal tissue, (phenytoin, cyclosporin, nifedipine, chronic use of non-steroidal anti-inflammatory drugs) * Presence of active caries lesions * Unwillingness to return for the follow-up examination * Wear partial prosthetic dentures removables * Participant has less than 20 teeth
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Halitosis are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
UZLeuven, Campus SintRafael
RECRUITINGLeuven, Belgium
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can everyday supplements boost gum disease therapy?
- Green tea rinse put to the test against braces bad breath
- Can pulling a loose tooth and putting it back save it?
- Gum fluid proteins eyed as link between smoking and periodontitis
- Gum fluid holds clues to Behçet's disease puzzle
- Magnifying the fight against gum disease: loupe vs microscope